Login to Your Account

PDUFA Passes the Senate, Awaits Debate on House Floor

By Mari Serebrov
Washington Editor

Friday, May 25, 2012
WASHINGTON – Biopharma has cause to celebrate as PDUFA V rolled through the Senate Thursday with little in the way of fireworks. The FDA Innovation and Safety Act (FDASIA), S. 3187, passed the Senate 96-1 after a full day of debate on various amendments.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription